Bekkers, E. | Search bioRxiv

bioRxiv2025

Fast and Accurate Peptide - MHC Structure Prediction via an Equivariant Diffusion Model

Accurate modeling of peptide-MHC (Major Histocompatibility Complex) structures is critical for the development of personalized cancer vaccines and T-cell therapies, as MHC proteins present peptides on the cell surface for immune recognition. Here, we introduce MHC-Diff, a specialized SE(3)-equivariant diffusion model leveraging Geometric Deep Learning to predict the 3D C-alpha atom structures of peptide-MHC complexes with high accuracy. Unlike previous deep learning models that generate a single static structure, our probabilistic approach samples multiple diverse candidates, capturing the inherent flexibility of peptide-MHC binding. Validated on the Pandora benchmark and experimental X-ray crystallography data, MHC-Diff achieves sub-angstrom accuracy, outperforming existing methods by a large margin while matching the inference speed of the fastest available techniques. By enabling rapid and highly accurate structure prediction across diverse peptide lengths and MHC alleles, MHC-Diff provides a powerful new tool for accelerating the design of next-generation cancer vaccines and T-cell therapies.

bioinformatics↗

bioRxiv2023

Improving generalizability for MHC-binding peptide predictions through structure-based geometric deep learning

The interaction between peptides and major histocompatibility complex (MHC) molecules is pivotal in autoimmunity, pathogen recognition and tumor immunity. Recent advances in cancer immunotherapies demand for more accurate computational prediction of MHC-bound peptides. We address the generalizability challenge of MHC-bound peptide predictions, revealing limitations in current sequence-based approaches. Our structure-based methods leveraging geometric deep learning (GDL) demonstrated promising improvement in generalizability across unseen MHC alleles. Further, we tackle data efficiency by introducing a self-supervised learning approach on structures (3D-SSL). Without being exposed to any binding affinity data, our 3D-SSL outperforms sequence-based methods trained on [~]90 times more datapoints. Finally, we demonstrate the resilience of structure-based GDL methods to biases in binding data on an Hepatitis B virus vaccine immunopeptidomics case study. This proof-of-concept study highlights structure-based methods potential to enhance generalizability and data efficiency, with important implications for data-intensive fields like T-cell receptor specificity predictions, paving the way for enhanced comprehension and manipulation of immune responses.

bioinformatics↗